Dave & Buster's (PLAY) reported earnings 30 days ago. What's next for the stock?

Stitch Fix (SFIX) reported earnings 30 days ago. What's next for the stock?

United Natural (UNFI) reported earnings 30 days ago. What's next for the stock?

GameStop (GME) reported earnings 30 days ago. What's next for the stock?

SCOTTSDALE, Ariz., July 10, 2025 (GLOBE NEWSWIRE) -- VIIRL Marketing, a digital marketing agency and software company, is pleased to announce the acquisition of the Yelp Division from Phoenix Online Advertising, an online marketing agency in Phoenix, Arizona.

RANCHO CORDOVA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the “Bank”), expects to report its financial results for the quarter ended June 30, 2025, after the stock market closes on Wednesday, July 23, 2025.

Positioned based on its Ability to Execute and Completeness of Vision New York, New York--(Newsfile Corp. - July 10, 2025) - Datadog, Inc. (NASDAQ: DDOG), the monitoring and security platform for cloud applications, today announced it has been named a Leader in the Gartner Magic Quadrant for Observability Platforms, 2025. This is the fifth consecutive year Gartner has positioned Datadog as a Leader in the Magic Quadrant.

IOVA Investors with Losses Encouraged to Contact Hagens Berman Before July 14th Deadline IOVA Investors with Losses Encouraged to Contact Hagens Berman Before July 14th Deadline

WMT is gaining with e-commerce strength and grocery comps, but valuation concerns and trade risks cloud the outlook.

TSLA eyes San Francisco for its next robotaxi rollout, but regulatory hurdles could slow its autonomous drive.

Vertiv is a leader in data-center cooling solutions.

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common units of XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (“XPLR” or the “Company”) (NYSE: XIFR) between September 27, 2023 and January 27, 2025, inclusive. For more information, submit a form at XPLR Infrastructure, LP Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive. For more information, submit a form at Centene Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.

Yesterday, Nvidia (Nasdaq: NVDA) became the first company to surpass a $4 trillion market capitalization. The AI chip giant did so on the strength of its position in the artificial intelligence race that has been sweeping the globe.

FSM's Q2 gold equivalent output rises 1.2% from Q1, as Lindero gains offset a dip at Seguela and lower silver at Caylloma.

OUST eyes a $20B LiDAR market with scalable, software-driven tech as EVs and autonomy fuel rising demand.

Fortinet's recurring revenues climb as demand for SASE and SecOps solutions drives its subscription model forward.

U.S. equities were mostly higher at midday, boosted by optimism in the travel industry. The Dow Jones Industrial Average and S&P 500 were up, while the Nasdaq fell.

MP Materials (NYSE:MP) shares surged almost 50% after it revealed the Pentagon has become its largest shareholder in a bid to boost the domestic supply of rare earth minerals. The US Department of Defense (DoD) has invested $400 million in MP Minerals' preferred stock, giving it a roughly 15% stake in the company.

Rhythm Pharmaceuticals jumps 36.6% after its oral drug bivamelagon shows strong BMI and hunger reductions in a phase II study in acquired hypothalamic obesity.